Close

Susquehanna Upgrades Endo International plc (ENDP) to Positive

Go back to Susquehanna Upgrades Endo International plc (ENDP) to Positive

Endo Reports Third Quarter 2016 Financial Results

November 8, 2016 6:30 AM EST

DUBLIN, Nov. 8, 2016 /PRNewswire/ --

Third quarter 2016 reported revenues of $884 million and diluted GAAP loss per share from continuing operations of $0.86 Third quarter 2016 adjusted diluted earnings per share (EPS) of $1.01 Company Reaffirms Full Year 2016 Revenues and Adjusted Diluted EPS Financial Guidance

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today reported third quarter 2016 financial results, including:

Revenues of $884 million including the addition of sales from its 2015 acquisition of Par Pharmaceutical, a 19 percent increase... More